New drug target for Her-2 related breast cancer

New research details exactly how the Her2 cancer gene promotes the progression and spread of breast cancer cells. The inactivation of a tumor suppression gene called Nischarin is among the mechanisms identified. The findings provide a new therapeutic target to block the function of Her2.

Read the whole article on Science Daily

More from Science Daily